XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 15.47%, Johnson & Johnson at 10.43%, AbbVie at 7.70%, UnitedHealth Group at 6.48%, and Merck & Co. at 5.43%.

Total Holdings

Top 10 Percentage

60.96%

Asset Class

Equity

ETF Category

Health

Assets

42.10B

PE Ratio

24.53

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	15.47%	5,642,137
2	JNJ	Johnson & Johnson	10.43%	17,169,161
3	ABBV	AbbVie Inc.	7.70%	12,601,443
4	UNH	UnitedHealth Group Incorporated	6.48%	6,477,226
5	MRK	Merck & Co., Inc.	5.43%	17,615,700
6	TMO	Thermo Fisher Scientific Inc.	3.63%	2,650,530
7	AMGN	Amgen Inc.	3.54%	3,849,390
8	ABT	Abbott Laboratories	3.11%	12,423,191
9	GILD	Gilead Sciences, Inc.	2.76%	8,855,370
10	PFE	Pfizer Inc.	2.40%	40,650,492
11	CVS	CVS Health Corporation	2.27%	9,100,339
12	BMY	Bristol-Myers Squibb Company	2.24%	14,564,839
13	ISRG	Intuitive Surgical, Inc.	2.12%	2,525,999
14	DHR	Danaher Corporation	2.09%	4,492,812
15	VRTX	Vertex Pharmaceuticals Incorporated	2.07%	1,810,243
16	SYK	Stryker Corporation	2.03%	2,460,850
17	MDT	Medtronic plc	1.86%	9,157,082
18	MCK	McKesson Corporation	1.76%	857,333
19	ELV	Elevance Health, Inc.	1.38%	1,548,860
20	CI	The Cigna Group	1.29%	1,886,751
21	REGN	Regeneron Pharmaceuticals, Inc.	1.25%	712,673
22	BSX	Boston Scientific Corporation	1.16%	10,601,234
23	HCA	HCA Healthcare, Inc.	1.04%	1,107,565
24	COR	Cencora, Inc.	1.03%	1,387,687
25	CAH	Cardinal Health, Inc.	0.90%	1,670,474

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Jul 30, 2026